web analytics
1.3 C
Munich
Sunday, November 27, 2022

Emergent Health (OTCMKTS: EMGE) the Reverse Merger on Regen Biowellness, Fusion Specialty Pharmacy & Revolutionary Biologistics

Emergent Health (OTCMKTS: EMGE) is making an explosive move up the charts after the Company reported it is closing in on the acquisition of Regen Biowellness, Inc. a distributor of various products in the plant-based and regenerative medical fields. The acquisition was subject to Regen having resolved and finalized a settlement with respect to all its litigation which was recently approved by the US Bankruptcy Court in New Jersey. The Acquisition is expected to close on or about August 1st, 2022. Jim Morrison, President and CEO of Regen has agreed to join Emergents Board of Directors upon the acquisition of Regen and additionally become the full-time CEO of Emergent upon the acquisition of Evolutionary Biologics. Emergent recently executed a letter of intent to acquire Evolutionary Biologics. The acquisition is expected to close within the next three weeks. 

The acquisition of Regen, along with the human and pet related products already in the Emergent family, through its subsidiaries Emergent OTC and Emergent Medical Foods for humans, as well as Pharmazu’s products for pets, plans to create a complete human and pet portfolio of products. With the previously announced acquisition of Fusion Pharmacy on June 29th 2022, Emergent intends to be a major participant in the field of OTC human and pet products. Fusion Specialty Pharmacy is a nationally accredited compounding pharmacy licensed in 27 states and located in St. George, Utah dedicated to formulating creative, individualized, and compounded medications. Fusion generated $3,801,497 in 2021 Revenues, an approximate 100% increase from 2020 Revenues of $1,971,599. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Emergent Health (OTCMKTS: EMGE) Curates Companies and Products, Develops and Sells in the Regenerative Health Space … Its products comprise ingestibles as well as topicals for the whole family. The company distributes its products online and through Content Based Shopping using Influencers to position products in their produced content throughout the United States and Internationally. PharmaZu Corp., its newly acquired subsidiary, is a pure play, e-commerce products and service provider focused on The Pet Community, Pet Pharmacy and Wellness using Influencers and their content, including the pet pharmacy, vet telehealth and pet wellness businesses. Emergent does not claim any of its products are approved by the FDA to diagnose, treat, cure or prevent any disease. 

EMGE is up big after the Company announced it is closing in on the acquisition of Regen Biowellness, Inc. a distributor of various products in the plant-based and regenerative medical fields. The acquisition was subject to Regen having resolved and finalized a settlement with respect to all its litigation. Regen is now ready to advance its business model and pursue its acquisition by Emergent. On July 19, 2022, Regen’s Bankruptcy Motion to Dismiss was approved by the US Bankruptcy Court in New Jersey. The Acquisition is expected to close on or about August 1st, 2022. 

Jim Morrison, President and CEO of Regen has agreed to join Emergents Board of Directors upon the acquisition of Regen and additionally become the full-time CEO of Emergent upon the acquisition of Evolutionary Biologics. Emergent recently executed a letter of intent to acquire Evolutionary Biologics. The acquisition is expected to close within the next three weeks. 

Mr. Morrison is a legend in the personal care industry, most notably as President of L’Oréal. While at L’Oréal, Morrison oversaw growth that averaged more than 20% year-over-year. He engineered the acquisitions of Redken and Matrix and led the company during a period of unprecedented growth during his tenure. He is considered one of the top brand strategists in the personal care space. Morrison has had a long history of working with celebrities in the beauty space. Business Week Magazine previously wrote, “Over the last two decades, Mr. Morrison has had a profound impact on the American Beauty Industry. In the industry’s history no other executive has had the level of financial responsibility or breadth of organizational experience as Jim. His devotion to, and success within the American Beauty Industry is unmatched.” 

To Find out the inside Scoop on EMGE Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

EMGE

Regen Biowellness products include:

Product with Issued Patents

Immuniain TM (Immune Booster) – Irreversibly-inactivated pepsinogen fragments for modulating immune function (Immune Booster- FDA Cleared) ImmunaZin contains an FDA approved New Dietary Ingredient (NDI), and the NDI # is 1140 Patent No. US 8,309,072; Patent Issued: November 13, 2012

Pending Patent Applications

Veterinary Cannabinoid and Menthol Compositions and Methods
Application No. 16/419,392; International Application PCT/US2019/048695

Cannabinoid and Menthol Compositions and Methods
US Application No. 16/419,336; International Application PCT/US2019/048691

Thin Film Toothpaste Strip, European Application
Product Name: KidzStrips ®

Thin Film Toothpaste Strip, Eurasian Application
Product Name: KidzStrips ®

Fertilizer
Product Name: HydroSoil ®, Water retaining Hemp enhanced fertilizer, water plant once every two weeks

Other Products

IcyEase
Adhesive Ice Pack for muscle/joint pain to cool surface and address pain.

Patent-pending, FDA pain claim in progress. IcyEase contains menthol, menthol is an approved pain relief ingredient in the FDA’s monograph for topical pain relief

Micro Voltage Trans Derm C
Patent application in progress for pain with unique and superior absorbing features due to wearer’s movement generated Micro Voltage

Silverpro – our only FDA approved medical device for the treatment of pain. Revolutionary technology combining genuine silver yarn with low-static carbon fibers, to create the world’s most advanced-compression pain relief fabric

The acquisition of Regen, along with the human and pet related products already in the Emergent family, through its subsidiaries Emergent OTC and Emergent Medical Foods for humans, as well as Pharmazu’s products for pets, plans to create a complete human and pet portfolio of products. With the previously announced acquisition of Fusion Pharmacy on June 29th 2022, Emergent intends to be a major participant in the field of OTC human and pet products.

For More on EMGE Subscribe Right Now!

Currently trading at a $3.3 million market valuation EMGE has 161,351,111 shares outstanding out of 200 million authorized, 50,327,516 of which are restricted leaving just 25,523,595 free trading shares and float of 4,083,089 shares. EMGE is an exciting story developing in small caps; while the Company has little assets, they do have some revenues and are virtually debt free. In recent months the Company is in the process of completing 3 major acquisitions including Fusion Specialty Pharmacy which generated $3,801,497 in 2021 Revenues, an approximate 100% increase from 2020 Revenues of $1,971,599. They are also acquiring Revolutionary Biologistics and just announced it is closing in on the acquisition of Regen Biowellness, Inc. a distributor of various products in the plant-based and regenerative medical fields. The Acquisition is expected to close on or about August 1st, 2022. Jim Morrison, President and CEO of Regen has agreed to join E.mergent’s Board of Directors upon the acquisition of Regen and additionally become the full-time CEO of Emergent upon the acquisition of Evolutionary Biologics. Mr. Morrison is a legend in the personal care industry, most notably as President of L’Oréal. While at L’Oréal, Morrison oversaw growth that averaged more than 20% year-over-year. He engineered the acquisitions of Redken and Matrix and led the company during a period of unprecedented growth during his tenure. EMGE is a reverse merger play; reverse merger stocks can be more explosive than biotech’s when the incoming Company has real value but is undiscovered to investors and we have covered many on the website that have gone from pennies to dollars. Microcapdaily will be covering EMGE so make sure you subscribe to Microcapdaily right now so you don’t miss it. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in EMGE either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.